Home
About Us
About Us
Board of Directors
Scientific Advisory Board
Management Team
Careers
For Researchers
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
For Partners
Our Current Partners
What We Are Looking For
For Patients
Accessing Kazia Drug Candidates in Clinical Trials
Accessing Kazia Drug Candidates for Compassionate Use
Resources for Patients
For Investors
Press Releases
ASX Announcements
Delisting from ASX
How to convert unlisted shares to ADSs
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Corporate Governance
Shareholder Services
Media Centre
Overview
Video
Coverage
Contact
Contact Us
Subscribe to email alerts
Heading &
Sub-heading can be edited through HQI
Home
>
Media Centre
>
Coverage
Overview
Video
Coverage
Coverage
8-Aug-2022
Stocks of the Hour: Kazia Therapeutics, Mesoblast, BHP &Oz Minerals
8-Aug-2022
ASX edges lower in morning trading, reporting season kicks off: Aus shares down 0.2% at noon
8-Aug-2022
Kazia Therapeutics gives progress report on GBM AGILE pivotal study for glioblastoma
7-Aug-2022
Kazia Therapeutics' promising data on treatment targeting brain metastases to be presented at conference
11-Jul-2022
Kazia Therapeutics forms new Scientific Advisory Board with world-leading experts in brain cancer
7-Jul-2022
Tech snaps 4-day winning streak, Iron ore miners rebound: ASX closes 0.8% higher
7-Jul-2022
Australia trade surplus hits record high, Chalice Mining soars on discovery: ASX up 0.2% at noon
7-Jul-2022
Stocks of the Hour: Elsight, Kazia Therapeutics, Chalice Mining
6-Jul-2022
Kazia Therapeutics gains US FDA Rare Paediatric Disease Designation for paxalisib in rare form of childhood brain cancer
30-Jun-2022
Kazia Therapeutics continues to make good progress on cancer treatment assets
Previous
1
2
3
4
5
6
7
8
Next
